| Dr Jami Nacole Goodwin, MD | |
|
1021 Coolidge St, Suite 2, Greeneville, TN 37743-4672 | |
| (423) 636-2300 | |
| (423) 636-0348 |
| Full Name | Dr Jami Nacole Goodwin |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 14 Years |
| Location | 1021 Coolidge St, Greeneville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811209620 | NPI | - | NPPES |
| P01326669 | Other | TN | PTAN |
| 1811209620 | Other | TN | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 51286 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Greeneville Community Hospital | Greeneville, TN | Hospital |
| Johnson City Medical Center | Johnson city, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Takoma Regional Hospital Inc | 8729189295 | 30 |
News Archive
Preliminary results from a large, randomized, placebo-controlled clinical trial for patients with primary gastrointestinal stromal tumor (GIST), a type of tumor usually found in the stomach or small intestine, showed that patients who received imatinib mesylate (Gleevec) after complete removal of their tumor were significantly less likely to have a recurrence of their cancer compared to those who did not receive imatinib.
Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too.
Results from a large study in Italy show that increasing body weight is associated with chronic obstructive pulmonary disease and asthma risk, independent of smoking history.
Physicians and health care officials on Wednesday called on Nevada lawmakers to support a bill ( SB 266) that would guarantee all pregnant women in the state have access to an HIV test as part of routine prenatal care, the Las Vegas Review-Journal reports.
› Verified 7 days ago
| Entity Name | Takoma Regional Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699819003 PECOS PAC ID: 8729189295 Enrollment ID: O20070727000394 |
News Archive
Preliminary results from a large, randomized, placebo-controlled clinical trial for patients with primary gastrointestinal stromal tumor (GIST), a type of tumor usually found in the stomach or small intestine, showed that patients who received imatinib mesylate (Gleevec) after complete removal of their tumor were significantly less likely to have a recurrence of their cancer compared to those who did not receive imatinib.
Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too.
Results from a large study in Italy show that increasing body weight is associated with chronic obstructive pulmonary disease and asthma risk, independent of smoking history.
Physicians and health care officials on Wednesday called on Nevada lawmakers to support a bill ( SB 266) that would guarantee all pregnant women in the state have access to an HIV test as part of routine prenatal care, the Las Vegas Review-Journal reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jami Nacole Goodwin, MD Po Box 37087, Baltimore, MD 21297-3087 Ph: (828) 687-5616 | Dr Jami Nacole Goodwin, MD 1021 Coolidge St, Suite 2, Greeneville, TN 37743-4672 Ph: (423) 636-2300 |
News Archive
Preliminary results from a large, randomized, placebo-controlled clinical trial for patients with primary gastrointestinal stromal tumor (GIST), a type of tumor usually found in the stomach or small intestine, showed that patients who received imatinib mesylate (Gleevec) after complete removal of their tumor were significantly less likely to have a recurrence of their cancer compared to those who did not receive imatinib.
Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too.
Results from a large study in Italy show that increasing body weight is associated with chronic obstructive pulmonary disease and asthma risk, independent of smoking history.
Physicians and health care officials on Wednesday called on Nevada lawmakers to support a bill ( SB 266) that would guarantee all pregnant women in the state have access to an HIV test as part of routine prenatal care, the Las Vegas Review-Journal reports.
› Verified 7 days ago
Dr. Howard E Herrell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1021 Coolidge St, Suite 2, Greeneville, TN 37743 Phone: 423-636-2300 Fax: 423-636-0348 | |
Amber Nicole Mullins, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1021 Coolidge St, Suite 2, Greeneville, TN 37743 Phone: 423-636-2300 Fax: 423-636-0348 | |
Dr. Harry Charles Nelson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1021 Coolidge St, Suite 2, Greeneville, TN 37743 Phone: 423-636-2300 Fax: 423-636-0348 |